This site is intended for healthcare professionals
  • Home
  • /
  • Guidelines
  • /
  • Complications of surgical procedures or medical ca...
  • /
  • Management of toxicities from immunotherapy: ESMO ...

Management of toxicities from immunotherapy: ESMO Guidelines

Read time: 1 mins
Last updated:18th Oct 2022
Management of toxicities from immunotherapy: European Society for Medical Oncology (ESMO) Clinical Practice Guideline for diagnosis, treatment and follow-up

This ESMO Clinical Practice Guideline provides key recommendations for managing immunotherapy-related toxicity.

The guideline covers assessment, diagnosis and treatment of the most common and severe immunotherapy-related toxicities.

Recommended assessment and treatment algorithms according to the grade of toxicity are provided.

The authors comprise a multidisciplinary group of experts from different institutions in Europe, Australia and the USA.

Recommendations are based on available scientific data and the authors’ collective expert opinion.


Read full guideline